BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33212545)

  • 21. Association between age and disease specific mortality in medullary thyroid cancer.
    Sahli ZT; Canner JK; Zeiger MA; Mathur A
    Am J Surg; 2021 Feb; 221(2):478-484. PubMed ID: 33010878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased therapeutic effect on medullary thyroid cancer using a combination of radiation and tyrosine kinase inhibitors.
    Sandblom V; Spetz J; Shubbar E; Montelius M; Ståhl I; Swanpalmer J; Nilsson O; Forssell-Aronsson E
    PLoS One; 2020; 15(5):e0233720. PubMed ID: 32459817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Medullary thyroid carcinoma].
    Tiedje V; Ting S; Dralle H; Schmid KW; Führer D
    Internist (Berl); 2015 Sep; 56(9):1019-31. PubMed ID: 26338063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Progression of diagnosis and treatment of medullary thyroid carcinoma].
    Wang X; Li C; Huang L; Shui CY; Liu W; Cai YC; Sun RH; Zhou YQ; Jiang J; Wang W; Zeng DF
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Apr; 54(4):306-310. PubMed ID: 30991785
    [No Abstract]   [Full Text] [Related]  

  • 25. Different outcomes in sporadic versus familial medullary thyroid cancer.
    Saltiki K; Simeakis G; Anagnostou E; Zapanti E; Anastasiou E; Alevizaki M
    Head Neck; 2019 Jan; 41(1):154-161. PubMed ID: 30548085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study.
    Castinetti F; Waguespack SG; Machens A; Uchino S; Hasse-Lazar K; Sanso G; Else T; Dvorakova S; Qi XP; Elisei R; Maia AL; Glod J; Lourenço DM; Valdes N; Mathiesen J; Wohllk N; Bandgar TR; Drui D; Korbonits M; Druce MR; Brain C; Kurzawinski T; Patocs A; Bugalho MJ; Lacroix A; Caron P; Fainstein-Day P; Borson Chazot F; Klein M; Links TP; Letizia C; Fugazzola L; Chabre O; Canu L; Cohen R; Tabarin A; Spehar Uroic A; Maiter D; Laboureau S; Mian C; Peczkowska M; Sebag F; Brue T; Mirebeau-Prunier D; Leclerc L; Bausch B; Berdelou A; Sukurai A; Vlcek P; Krajewska J; Barontini M; Vaz Ferreira Vargas C; Valerio L; Ceolin L; Akshintala S; Hoff A; Godballe C; Jarzab B; Jimenez C; Eng C; Imai T; Schlumberger M; Grubbs E; Dralle H; Neumann HP; Baudin E
    Lancet Diabetes Endocrinol; 2019 Mar; 7(3):213-220. PubMed ID: 30660595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Metastatic medullary thyroid carcinoma in a child with multiple endocrine neoplasia 2B. Efficiency of medium-term treatment with vandetanib without thyroid surgery].
    Segura D; Dupuis C; Chabre O; Piolat C; Durand C; Plantaz D
    Arch Pediatr; 2016 Aug; 23(8):840-4. PubMed ID: 27345554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk and survival of patients with medullary thyroid cancer: National perspective.
    Al-Qurayshi Z; Khadra H; Chang K; Pagedar N; Randolph GW; Kandil E
    Oral Oncol; 2018 Aug; 83():59-63. PubMed ID: 30098780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of biochemical cure in patients with medullary thyroid cancer.
    Machens A; Lorenz K; Dralle H
    Br J Surg; 2020 May; 107(6):695-704. PubMed ID: 32108330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology and Clinical Presentation of Medullary Thyroid Carcinoma.
    Raue F; Frank-Raue K
    Recent Results Cancer Res; 2015; 204():61-90. PubMed ID: 26494384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of CDKN2C Copy Number in Sporadic Medullary Thyroid Carcinoma.
    Grubbs EG; Williams MD; Scheet P; Vattathil S; Perrier ND; Lee JE; Gagel RF; Hai T; Feng L; Cabanillas ME; Cote GJ
    Thyroid; 2016 Nov; 26(11):1553-1562. PubMed ID: 27610696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive Value of
    Werner RA; Schmid JS; Higuchi T; Javadi MS; Rowe SP; Märkl B; Aulmann C; Fassnacht M; Kroiss M; Reiners C; Buck AK; Kreissl MC; Lapa C
    J Nucl Med; 2018 May; 59(5):756-761. PubMed ID: 29025983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Volumetric and texture analysis of pretherapeutic
    Werner RA; Bundschuh RA; Higuchi T; Javadi MS; Rowe SP; Zsótér N; Kroiss M; Fassnacht M; Buck AK; Kreissl MC; Lapa C
    Endocrine; 2019 Feb; 63(2):293-300. PubMed ID: 30206772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2A and 2B.
    Skinner MA; DeBenedetti MK; Moley JF; Norton JA; Wells SA
    J Pediatr Surg; 1996 Jan; 31(1):177-81; discussion 181-2. PubMed ID: 8632274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PROGNOSTIC VARIABLES AFFECTING PRIMARY TREATMENT OUTCOME FOR MEDULLARY THYROID CANCER.
    Momin S; Chute D; Burkey B; Scharpf J
    Endocr Pract; 2017 Sep; 23(9):1053-1058. PubMed ID: 28683235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. International Medullary Thyroid Carcinoma Grading System: A Validated Grading System for Medullary Thyroid Carcinoma.
    Xu B; Fuchs TL; Ahmadi S; Alghamdi M; Alzumaili B; Bani MA; Baudin E; Chou A; De Leo A; Fagin JA; Ganly I; Glover A; Hartl D; Kanaan C; Khneisser P; Najdawi F; Nigam A; Papachristos A; Repaci A; Spanheimer PM; Solaroli E; Untch BR; Barletta JA; Tallini G; Al Ghuzlan A; Gill AJ; Ghossein RA
    J Clin Oncol; 2022 Jan; 40(1):96-104. PubMed ID: 34731032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Temporal Trends in the Presentation, Treatment, and Outcome of Medullary Thyroid Carcinoma: An Israeli Multicenter Study.
    Hirsch D; Twito O; Levy S; Bachar G; Robenshtok E; Gross DJ; Mazeh H; Benbassat C; Grozinsky-Glasberg S
    Thyroid; 2018 Mar; 28(3):369-376. PubMed ID: 29402183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prognostic value of lymph node ratio in Medullary thyroid carcinoma: A multi-center study.
    Rozenblat T; Hirsch D; Robenshtok E; Grozinsky-Glasberg S; Gross DJ; Mazeh H; Benbassat C; Twito O; Levy S; Mizrachi A; Shpitzer T; Bachar G
    Eur J Surg Oncol; 2020 Nov; 46(11):2023-2028. PubMed ID: 32389525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Barriers to the recognition of medullary thyroid carcinoma on FNA: Implications relevant to the new American Thyroid Association guidelines.
    Dyhdalo KS; Chute DJ
    Cancer Cytopathol; 2018 Jun; 126(6):397-405. PubMed ID: 29579362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medullary thyroid carcinoma: prognostic factors and treatment.
    Rougier P; Parmentier C; Laplanche A; Lefevre M; Travagli JP; Caillou B; Schlumberger M; Lacour J; Tubiana M
    Int J Radiat Oncol Biol Phys; 1983 Feb; 9(2):161-9. PubMed ID: 6833017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.